Cefepime is a fourth-generation cephalosporin antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative bacteria [1]. It is commonly formulated as cefepime hydrochloride, which is a sterile, semi-synthetic, broad-spectrum, injectable cephalosporin antibiotic [2].
What are the primary uses for Cefepime?
Cefepime is prescribed to treat a range of bacterial infections, including pneumonia, urinary tract infections, skin and skin structure infections, intra-abdominal infections, and febrile neutropenia [2]. Its efficacy extends to serious infections such as meningitis, bacteremia, and septicemia caused by susceptible organisms [3].
How is Cefepime administered?
Cefepime is typically administered intravenously (IV) or intramuscularly (IM) [2]. The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient's renal function [3].
What is the difference between Cefepime and other cephalosporins?
As a fourth-generation cephalosporin, cefepime exhibits enhanced activity against many Gram-negative bacteria, including Enterobacteriaceae and Pseudomonas aeruginosa, compared to earlier generations [1]. It also maintains good activity against many Gram-positive organisms [1]. This broader spectrum of activity makes it a valuable option for treating serious and complex infections [3].
When does Cefepime's patent protection expire?
Information regarding specific patent expiry dates for cefepime can be found through patent databases. DrugPatentWatch.com provides comprehensive data on drug patents, including expiry timelines [4].
Are there generic versions of Cefepime available?
Yes, generic versions of cefepime are available on the market [5]. The availability of generics can impact pricing and market competition [4].